Covid-19
Germany approves clinical trial of coronavirus immunity vaccines
Germany has approved clinical trials of multiple vaccines developed by German biotech company, BioNTech, for treatment of coronavirus. Scientists were said to be monitoring the effectiveness of the vaccines in generating immunity against coronavirus. The clinical trial will be starting with 200 participants of 18 to 55 years age bracket.
Statistics from Johns Hopkins University shows that coronavirus has killed over 177,000 people and infected 2.5 million across the world. This was identified to have given impetus to the race to develop vaccines that can contain the spread of coronavirus and the associated deaths across the world.
About 86 teams were identified to be engaged on research and study for coronavirus vaccines across the world.
-
Football3 days agoFrance confirms U-20 Women’s World Cup participation amid FIFA-UEFA rift
-
Business3 days agoNigeria’s external debt service falls 31.5% to $954m in Q1 2026
-
Latest3 days agoNFF denies calling for Infantino’s resignation
-
Featured3 days agoOsun Governorship Election: Adeleke faces tough test as APC, ADC mount challenge
-
Business3 days agoNNPC faces fresh scrutiny over oil licensing, production claims, transparency
-
Latest3 days agoMessi reportedly faced multiple bomb threats during 2026 World Cup
-
Business3 days agoNaira at ₦1,360/$: Can the currency’s new stability last?
-
Business1 week agoBreaking: NNPCL reduces pump price of petrol as competition intensifies